ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 85 filers reported holding ONCOMED PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $137,000 | +242.5% | 132,597 | +142.4% | 0.00% | – |
| Q4 2018 | $40,000 | – | 54,700 | +101196.3% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 54 | -98.2% | 0.00% | – |
| Q4 2017 | $12,000 | +140.0% | 2,984 | +110.7% | 0.00% | – |
| Q3 2017 | $5,000 | -92.1% | 1,416 | -92.7% | 0.00% | – |
| Q2 2017 | $63,000 | -94.2% | 19,396 | -83.5% | 0.00% | -100.0% |
| Q1 2017 | $1,084,000 | +10.7% | 117,885 | -7.3% | 0.00% | 0.0% |
| Q4 2016 | $979,000 | -5.8% | 127,109 | +39.6% | 0.00% | 0.0% |
| Q3 2016 | $1,039,000 | +91.0% | 91,034 | +105.2% | 0.00% | – |
| Q2 2016 | $544,000 | +34.0% | 44,360 | +10.2% | 0.00% | – |
| Q1 2016 | $406,000 | -40.1% | 40,244 | +33.5% | 0.00% | – |
| Q4 2015 | $678,000 | -30.0% | 30,155 | -48.4% | 0.00% | -100.0% |
| Q3 2015 | $969,000 | -17.5% | 58,475 | +11.9% | 0.00% | 0.0% |
| Q2 2015 | $1,174,000 | +6.7% | 52,242 | +22.2% | 0.00% | 0.0% |
| Q1 2015 | $1,100,000 | -48.3% | 42,756 | -56.3% | 0.00% | 0.0% |
| Q4 2014 | $2,128,000 | +11.5% | 97,951 | -2.9% | 0.00% | 0.0% |
| Q3 2014 | $1,908,000 | +1.1% | 100,889 | +24.4% | 0.00% | 0.0% |
| Q2 2014 | $1,888,000 | -17.2% | 81,113 | +19.7% | 0.00% | -50.0% |
| Q1 2014 | $2,280,000 | -34.2% | 67,773 | -42.2% | 0.00% | 0.0% |
| Q4 2013 | $3,463,000 | +94.0% | 117,339 | +0.6% | 0.00% | +100.0% |
| Q3 2013 | $1,785,000 | – | 116,639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|